Literature DB >> 19007132

N-acyldihydropyridones as synthetic intermediates. A stereoselective synthesis of acyclic amino alcohols containing multiple chiral centers.

W Stephen McCall1, Teresa Abad Grillo, Daniel L Comins.   

Abstract

Various multisubstituted piperidines containing a phenyl group at C-2 can be opened regio- and stereoselectively with cyanogen bromide. The ring-opened products contain useful cyanamide and benzylic bromide functional groups. The benzyl bromide can be cleanly reduced, or substituted with various nucleophiles via an S(N)2 process to add additional heteroatoms stereoselectively. This methodology is useful for the stereoselective synthesis of uniquely substituted alkylamine derivatives containing multiple chiral centers and various functionality. Diastereomerically pure amino alcohols containing three to five contiguous stereocenters were prepared using this strategy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19007132      PMCID: PMC2736366          DOI: 10.1021/jo802029y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  12 in total

1.  A six-step asymmetric synthesis of (+)-hyperaspine.

Authors:  Daniel L Comins; James J Sahn
Journal:  Org Lett       Date:  2005-11-10       Impact factor: 6.005

2.  Tandem directed lithiations of N-Boc-1,2-dihydropyridines toward highly functionalized 2,3-dihydro-4-pyridones.

Authors:  Damian W Young; Daniel L Comins
Journal:  Org Lett       Date:  2005-12-08       Impact factor: 6.005

3.  The Mukaiyama-Michael reaction of N-acyl-2,3-dihydro-4-pyridones: regio- and stereoselective synthesis of cis-2,6-disubstituted 1,2,5,6-tetrahydropyridines.

Authors:  J T Kuethe; D L Comins
Journal:  Org Lett       Date:  1999-10-07       Impact factor: 6.005

Review 4.  Synthetic applications of chiral 2,3-dihydro-4-pyridones.

Authors:  Sajan Joseph; Daniel L Comins
Journal:  Curr Opin Drug Discov Devel       Date:  2002-11

5.  Directed reductive amination of beta-hydroxy-ketones: convergent assembly of the ritonavir/lopinavir core.

Authors:  Dirk Menche; Fatih Arikan; Jun Li; Sven Rudolph
Journal:  Org Lett       Date:  2007-01-18       Impact factor: 6.005

6.  Synthetic studies toward (-)-FR901483 using a conjugate allylation to install the C-1 quaternary carbon.

Authors:  Dimitar B Gotchev; Daniel L Comins
Journal:  J Org Chem       Date:  2006-12-08       Impact factor: 4.354

7.  Stereoselective synthesis of acyclic amino alcohols via von Braun ring opening of chiral piperidines.

Authors:  W Stephen McCall; Teresa Abad Grillo; Daniel L Comins
Journal:  Org Lett       Date:  2008-06-27       Impact factor: 6.005

8.  Synthesis of (R)-dihydropyridones as key intermediates for an efficient access to piperidine alkaloids.

Authors:  Evangelia N Tzanetou; Konstantinos M Kasiotis; Prokopios Magiatis; Serkos A Haroutounian
Journal:  Molecules       Date:  2007-04-10       Impact factor: 4.411

9.  Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517).

Authors:  S H Rosenberg; K P Spina; S L Condon; J Polakowski; Z Yao; P Kovar; H H Stein; J Cohen; J L Barlow; V Klinghofer
Journal:  J Med Chem       Date:  1993-02-19       Impact factor: 7.446

10.  Synthesis of the benzo-fused indolizidine alkaloid mimics.

Authors:  Daniel L Comins; Kazuhiro Higuchi
Journal:  Beilstein J Org Chem       Date:  2007-11-30       Impact factor: 2.883

View more
  2 in total

1.  Total synthesis of alkaloid 205B.

Authors:  Sergey V Tsukanov; Daniel L Comins
Journal:  J Org Chem       Date:  2014-09-17       Impact factor: 4.354

2.  Microwave-assisted synthesis of novel 2,3-dihydro-4-pyridinones.

Authors:  Bahjat A Saeed; Rita S Elias; Wisam A Radhi
Journal:  Molecules       Date:  2010-11-17       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.